Archive - January 2018

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA"

Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects a baby as it grows in the womb. Now, new research suggests the virus damages a pregnant mother's placenta, an organ inside a woman's uterus that helps protect and care for a growing baby. A paper published in Nature Communications describes how Zika virus infection

New research conducted by a group of scientists at the University of Southern California (USC), whose findings are published in the Journal of Clinical Oncology,suggests that regular exercise could extend the life expectancy of breast cancer survivors, by lowering their increased risk of type 2 diabetes, heart disease, and potentially breast cancer recurrence. According to Dr. Christina Dieli-Conwright, the lead author and assistant professor of research at USC Division of Biokinesiology

You asked and we are delivering! We heard from many members, both those who have attended the Essentially Women Focus Conference and those who have been unable to. And, based on these conversations and post-event surveys, members overwhelmingly would like to see Focus return to the spring. Well, we have great news – the Focus Conference will be moving to the spring in 2019! This does mean 2018 will become a transition year as we plan for Spring 2019, but just because there’s no Focus

Essentially Women has been working towards getting a bill introduced to allow Medicare coverage for custom breast prosthesis. We have been in communication with several legislative offices that have requested additional information. This is where we need your help! We need to hear from patients from both perspectives: those who were able to obtain coverage for their custom breast prosthesis and those who are not covered. As you are aware, Medicare created L8035, a code for custom breast prosthesis

Have you tried our New Gold Line of Supports? We couldn't be more in love, and we want to share them with you! Valentine's Day Sale Starting Now- February 14th Order 3 or more of our new products and receive FREE SHIPPING It's You Babe, LLC |[email protected]| Itsyoubabe.com

Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes -- MSH6 and PMS2 -- approximately doubles a woman's risk of developing breast cancer by age 60. The study, in collaboration with GeneDx, a genetic testing company, was published online today in Genetics in Medicine. The two genes were previously known to cause Lynch syndrome, an inherited condition that raises the risk of colorectal,

Researchers have found a way to deplete breast cancer cells of energy and thus halt their growth. The findings may one day help to alleviate treatment-resistant breast cancer. According to the American Cancer Society (ACS), around 2 in 3 cancers are hormone-driven. This means that the breast cancer cells possess proteins that act as hormone receptors and feed off of estrogen or progesterone. These hormones help the breast cancer to spread, so hormone

The use and recommendation of chemotherapy for women with both node-negative and node-positive early-stage breast cancer has declined in recent years, according to published survey results. “For patients with early-stage breast cancer, we’ve seen a significant decline in chemotherapy use over the last few years without a real change in evidence,” Allison Kurian, MD, associate professor of medicine at Stanford University, said in a press release accompanying